Log in
FREE 15-Day Trial
Intelligent Investor
Intelligent Investor
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. Avecho Biotechnology Limited (AVE)
  6. Company Financials

Avecho Biotechnology Limited (ASX: AVE) - Financials

- Current share price for AVE : $0.003

Avecho Biotechnology Limited (AVE) develops and commercialises innovative Human and Animal Health products using its proprietary drug delivery system called TPM (Tocopherol Phosphate Mixture). TPM is derived from Vitamin E using unique, proprietary and patented processes and is proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients. Major projects include delivering TPM enhanced injectable, oral and topical products for the human health market, including the recently announced application of TPM to cannabinoids.

Intelligent Investor free trial for buy hold sell stock recommendations

AVE Per Share

Year to Jun Sales Cashflow Earnings Dividends Franking Book Value Average
Annual P/E		 Relative P/E Shareholder Return
2023 -0.1 ¢ -0.1 ¢ 0 ¢ 0% 0 0% -76.7%
2022 -0.1 ¢ -0.1 ¢ 0 ¢ 0% 0 0% 0%
2021 -0.2 ¢ -0.2 ¢ 0 ¢ 0% 0 0% -48.3%

AVE Capital Structure

Total Debt Interest Long Term Debt Percent Debt Preferred Stock Share Equity Percent Equity
$175.20 $15.40 $98.20 2% $0.00 $6,378.00 98%
Note: All dollars in thousands ('000) for the table above

AVE Historical Financials

2023 2022 2021
Revenue ($M) 0.5 1.2 0.8
Operating Margin (%) -692.2 -174.9 -375.3
Depreciation ($M) -0.2 -0.2 -0.1
Amortisation ($M)
Net Profit Before Abs ($M) -3.4 -2.3 -3.4
Net Profit After Abs ($M) -3.4 -2.3 -3.4
Income Tax Rate (%)
Net Profit Margin (%) -725.7 -194.2 -430.5
Employees ($T)
Long Term Debt ($M) 0.1 0.2
Shareholders Equity ($M) 6.4 2.4 4.5
Return on Capital (%) -53 -90 -75
Return on Equity (%) -53.9 -96.6 -75.3
Payout Ratio (%)

AVE Cashflow

2023 2022 2021
Customer Receipts ($M) 1 1 1
Net Operating Cashflow ($M) -3.18 -1.67 -3.1
Net Investing Cashflow ($M)
Net Financing Cashflow ($M) 7 5

AVE Market & Earnings

2023 2022 2021
Market Cap ($M) 11 28 28
Net Gearing (%) -83.6 -50.4 -69.9
Net Interest Cover (%) 171.5 -1,169 -360.7
Dividend Yield (%)
NTA Per Share ($)
EBITDA ($M) -3.28 -2.11 -2.98
EBIT ($M) -3.46 -2.34 -3.41
EBT Before Abs ($M) -3.44 -2.34 -3.42

AVE Balance Sheet

2023 2022 2021
Cash ($M) 5.5 1.47 3.26
Debtors ($M) 0.04
Other Debtors ($M) 1.1 0.75 1.09
Prepayments ($M) 0.3 0.24 0.22
Inventories ($M) 0.1 0.4 0.2
Current Investments ($M)
Other Current Assets ($M)
Total Current Assets ($M) 7 2.85 4.81
Receivables ($M)
Inventories ($M)
Property, Plant & Equipment ($M) 0.32 1.22 0.93
Accumulated Depreciation ($M) -0.75 -0.59
Intangibles ex. Goodwill ($M) 0.03 0.1
Goodwill ($M)
Future Income Tax Benefit ($M)
Non-Current Investments ($M)
Other Non-Current Assets ($M)
Total Non-Current Assets ($M) 0.32 0.49 0.44
Total Assets ($M) 7.32 3.35 5.25
Accounts Payable ($M) 0.18 0.28 0.28
Provisions ($M) 0.43 0.4 0.34
Short Term Debt ($M) 0.08 0.07 0.08
Other Current Liabilities ($M) 0.16
Total Current Liabilities ($M) 0.84 0.75 0.7
Creditors ($M)
Long Term Debt ($M) 0.1 0.18 0.01
Provisions ($M)
Other Non-Current Liabilities ($M)
Total Non-Current Liabilities ($M) 0.1 0.18 0.01
Total Liabilities ($M) 0.94 0.92 0.71
Share Capital ($M) 244.6 237.5 237.6
Reserves ex. Share Premium ($M) 29.2 29 29
Share Premium Reserve ($M)
Retained Profits ($M) -267.4 -264.1 -262.1
Other Shareholders Equity ($M)
Convertible Equity ($M)
Outside Equity Interest ($M)
Total Shareholders Equity ($M) 6.38 2.42 4.54

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.